✦ LIBER ✦

Budget Impact Of Crizotinib For Alk-Positive Advanced Non-Small Cell Lung Cancer (Nsclc) In Colombia

✍ Scribed by Rosado-Buzzo, A.; Garcia-Mollinedo, L.; Luna-Casas, G.; Mould-Quevedo, J.F.; Gutierrez-Ardila, M.V.; Vargas Zea, N.

Book ID: 122174478
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 71 KB
Volume: 16
Category: Article
ISSN: 1098-3015
DOI: 10.1016/j.jval.2013.03.643

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Crizotinib: A New Treatment Option for A

Crizotinib: A New Treatment Option for ALK-Positive Non-Small Cell Lung Cancer

✍ O'Bryant, C. L.; Wenger, S. D.; Kim, M.; Thompson, L. A. 📂 Article 📅 2013 🏛 Harvey Whitney Books Company 🌐 English ⚖ 192 KB

369 Timing of responses to crizotinib (P

369 Timing of responses to crizotinib (PF-02341066) in anaplastic lymphoma kinase (ALK)-positive patients with advanced non-small cell lung cancer (NSCLC)

✍ B. Solomon; Y.J. Bang; D.R. Camidge; A.J. Iafrate; E.L. Kwak; R.G. Maki; S.I. Ou 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Cost Effectiveness of EML4-ALK Fusion Te

Cost Effectiveness of EML4-ALK Fusion Testing and First-Line Crizotinib Treatment for Patients With Advanced ALK-Positive Non-Small-Cell Lung Cancer

✍ Djalalov, S.; Beca, J.; Hoch, J. S.; Krahn, M.; Tsao, M.-S.; Cutz, J.-C.; Leighl 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 306 KB

3030 POSTER Preliminary Characterization

3030 POSTER Preliminary Characterization of Visual Events Reported by Patients (Pts) Receiving Crizotinib for the Treatment of Advanced ALK-Positive Non-Small Cell Lung Cancer (NSCLC)

✍ B. Solomon; A. Chiappori; A. Lamb; M.C. Gawlicki; D.W. Kim; K. Park; R. Salgia; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Pemetrexed-based chemotherapy in patient

Pemetrexed-based chemotherapy in patients with advanced, ALK-positive non-small cell lung cancer

✍ Shaw, A. T.; Varghese, A. M.; Solomon, B. J.; Costa, D. B.; Novello, S.; Mino-Ke 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 305 KB

Severe Acute Interstitial Lung Disease A

Severe Acute Interstitial Lung Disease After Crizotinib Therapy in a Patient With EML4-ALK-Positive Non-Small-Cell Lung Cancer

✍ Tamiya, A.; Okamoto, I.; Miyazaki, M.; Shimizu, S.; Kitaichi, M.; Nakagawa, K. 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 819 KB